Eltrombo 50 mg Tablet (Eltrombopag 50mg)

Eltrombo 50 mg (Eltrombopag 50mg) is a prescribed medication indicated for treating low platelet count levels caused by chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. Platelets play a crucial role in preventing bleeding. Additionally, Eltrombo 50 mg (Eltrombopag 50mg) is used to manage severe aplastic anemia. By stimulating bone marrow cell production, it aids in generating more platelets, thus reducing the risk of bleeding.

This medication is administered to patients with chronic immune thrombocytopenic purpura (ITP) to minimize or prevent bleeding. As a thrombopoietin agonist, it facilitates the production of new platelets in the bloodstream. Eltrombo 50 mg (Eltrombopag 50mg) is suitable for children aged one and above, as well as adults. Typically, it is utilized when other treatment options, including conventional medicines and spleen removal surgery, have proven ineffective. Moreover, this tablet may be employed to elevate platelet counts in patients with hepatitis C and aplastic anemia.

Advantages of Eltrombo 50 mg (Eltrombopag 50mg):

• Eltrombo 50 (Eltrombopag 50mg) is prescribed to treat individuals with low platelet levels caused by chronic immune thrombocytopenia (ITP). It is typically recommended for patients who have not responded well to conventional medications or spleen removal surgery.
• The medication is also used to increase platelet levels in individuals with chronic hepatitis C virus infection. Eltrombo 50 (Eltrombopag 50mg) is often taken alongside other drugs during or before the treatment process.
• Eltrombo 50 (Eltrombopag 50mg) is utilized in the treatment of severe aplastic anemia, a condition characterized by bone marrow failure resulting in low platelet and cell counts. It is typically administered alongside other medications to address this condition effectively.

Administration of Eltrombo 50 mg (Eltrombopag 50mg):

Eltrombo 50 mg (Eltrombopag 50mg) should only be taken under the supervision and prescription of a doctor. The dosage and duration of the course must be followed as per the doctor’s instructions. The tablets should be swallowed whole and not crushed or broken. They can be taken with or without water, without chewing. For optimal effectiveness, it is advisable to take the medication on an empty stomach.

Consistency in taking the medicine at the same time every day is crucial for the patient’s recovery, as missing a dose can hinder progress. Following this routine helps the medication work more effectively. Unless otherwise advised by the doctor, the patient should complete the entire prescribed course of treatment. Proper storage of the medicine is essential, and it should not be left exposed for extended periods. Store it at room temperature, ideally between 10 to 30°C, to maintain its efficacy and prevent spoilage.

When should Eltrombo 50 mg (Eltrombopag 50mg) be avoided or used cautiously?

Patients with kidney problems, experiencing symptoms such as dizziness, weakness, or drowsiness as a result of medication, pregnant individuals, those with known infections, breastfeeding women, or individuals taking medications to lower cholesterol levels should exercise caution and consult with their healthcare provider before proceeding.

It is important to prioritize safety and ensure appropriate medical guidance in these circumstances:

• If patients have kidney problems
• If patients are feeling dizziness, weakness, or drowsiness due to taking the medicine
• If patients are pregnant
• If patients have any known infections
• If patients are breastfeeding
• If patients are taking medicines to lower cholesterol level

Most common side-effects of Eltrombo 50 mg (Eltrombopag 50mg):

• Nausea and Vomiting
• Fever
• Flu and cough
• Headache
• Muscle pain and tiredness
• Loss of appetite
• Diarrhea
• Increased liver enzymes
• Urinary tract infection
• Upper respiratory tract infection